purinergic P2 receptor antagonists

Preferred Label : purinergic P2 receptor antagonists;

MeSH definition : Compounds that bind to and block the stimulation of PURINERGIC P2 RECEPTORS.;

MeSH synonym : P2 purinoceptor antagonists; antagonists, P2 purinoceptor; purinoceptor antagonists, P2; Purinergic P2 Receptor Blockers; P2 Purinoceptor Blockers; Blockers, P2 Purinoceptor; Purinoceptor Blockers, P2;

Is substance : O;

action pharmacologique : O;

Détails

Origin ID

D058919;

UMLS CUI

C2936574;

Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- analysis [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- economics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
MeSH Descriptor(s) used for indexing
- receptors, purinergic P2 [MeSH Descriptor]
Record concept(s)
- purinergic P2 receptor antagonists [MeSH concept]
Semantic type(s)
- Pharmacologic Substance [UMLS semantic type]
Substance(s)
- (6-(6-(3-ethylureido)-9H-purin-9-yl)-2-styryltetrahydrofuro(3,4-d)(1,3)dioxol-4-yl)methyl dihydrogen phosphate [MeSH Supplementary Concept]
- 1-(N,O-bis(isoquinolinesulfonyl)-N-methyltyrosyl)-4-(4-fluorophenyl)piperazine [MeSH Supplementary Concept]
- 2,2'-pyridylisatogen tosylate [MeSH Supplementary Concept]
- 2-(2-(6-methylaminopurin-9-yl)ethyl)propane-1,3-bisoxy(diammonium phosphate) [MeSH Supplementary Concept]
- 4-((4-(1-(ethoxycarbonyl)-1-methylethoxy)-7-methyl-2-quinolyl)carbamoyl)-5-(4-(ethoxycarbonyl)piperazin-1-yl)-5-oxopentanoic acid [MeSH Supplementary Concept]
- 4-(2-iodo-6-methylaminopurin-9-yl)-1-((phosphato)methyl)-2-(phosphato)bicyclo(3.1.0)hexane [MeSH Supplementary Concept]
- 8,8',8'',8'''-(carbonylbis(imino-5,13-benzenetriyl-bis(carbonylimino)))tetrakisnaphthalene-1,3,5-trisulfonic acid [MeSH Supplementary Concept]
- AR C109318XX [MeSH Supplementary Concept]
- INS 50589 [MeSH Supplementary Concept]
- MRS 2220 [MeSH Supplementary Concept]
- N-(adamantan-1-ylmethyl)-5-((3-aminopyrrolidin-1-yl)methyl)-2-chlorobenzamide [MeSH Supplementary Concept]
- pyridoxal-5'-phosphate-6-(2'-naphthylazo-6'-nitro-4',8'-disulfonate) [MeSH Supplementary Concept]
- uridine-5'-O-(3-thiotriphosphate) [MeSH Supplementary Concept]

Position du mot-clé dans l'(les) arborescence(s) :

Vous pouvez consulter :

recommendations
documents concerning education
documents for patients